Structural basis of the CD8αβ/MHC class I interaction: focused recognition orients CD8β to a T cell proximal position

Journal of Immunology

Volumn 183, Issue 4, 2009, Pages 2554-2564

  Wang, Rui ^a   Natarajan, Kannan ^a   Margulies, David H ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA 2 MICROGLOBULIN; CD8 ANTIGEN; CD8ALPHA ANTIGEN; CD8BETA ANTIGEN; HETERODIMER; HOMODIMER; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; UNCLASSIFIED DRUG; CD8ALPHABETA ANTIGEN; H2 ANTIGEN; HISTOCOMPATIBILITY ANTIGEN H 2D(B); HISTOCOMPATIBILITY ANTIGEN H-2D(B);

ANTIGEN FUNCTION; ARTICLE; CELL MATURATION; CELL MEMBRANE; CONTROLLED STUDY; GENE INTERACTION; HUMAN; LYMPHOID CELL; MOUSE; MUTAGENESIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; SIGNAL TRANSDUCTION; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; AMINO ACID SEQUENCE; ANIMAL; CHEMISTRY; CRYSTALLIZATION; GENETICS; IMMUNOLOGY; METABOLISM; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; PROTEIN BINDING; PROTEIN MULTIMERIZATION; X RAY DIFFRACTION;

AMINO ACID SEQUENCE; ANIMALS; ANTIGENS, CD8; BETA 2-MICROGLOBULIN; CRYSTALLIZATION; DNA MUTATIONAL ANALYSIS; H-2 ANTIGENS; MICE; MOLECULAR SEQUENCE DATA; PROTEIN BINDING; PROTEIN MULTIMERIZATION; T-LYMPHOCYTES; X-RAY DIFFRACTION;

EID: 70149122200     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.0901276     Document Type: Article

References (83)

1. Laugel, B., H. A. van den Berg, E. Gostick, D. K. Cole, L. Wooldridge, J. Boulter, A. Milicic, D. A. Price, and A. K. Sewell. 2007. Different T cell receptor affinity thresholds and CD8 coreceptor dependence govern cytotoxic T lymphocyte activation and tetramer binding properties. J. Biol. Chem. 282: 23799-23810.
2. Singer, A., and R. Bosselut. 2004. CD4/CD8 coreceptors in thymocyte development, selection, and lineage commitment: analysis of the CD4/CD8 lineage decision. Adv. Immunol. 83: 91-131.
3. Zamoyska, R. 1998. CD4 and CD8: modulators of T-cell receptor recognition of antigen and of immune responses? Curr. Opin. Immunol. 10: 82-87. (Pubitemid 28112084)
4. Chan, I. T., A. Limmer, M. C. Louie, E. D. Bullock, W. P. Fung-Leung, T. W. Mak, and D. Y. Loh. 1993. Thymic selection of cytotoxic T cells independent of CD8 α-Lck association. Science 261: 1581-1584.
5. Xu, C., E. Gagnon, M. E. Call, J. R. Schnell, C. D. Schwieters, C. V. Carman, J. J. Chou, and K. W. Wucherpfennig. 2008. Regulation of T cell receptor activation by dynamic membrane binding of the CD3ε cytoplasmic tyrosine-based motif. Cell 135: 702-713.
6. Aivazian, D., and L. J. Stern. 2000. Phosphorylation of T cell receptor ζ is regulated by a lipid dependent folding transition. Nat. Struct. Biol. 7: 1023-1026.
7. Garcia, K. C., C. A. Scott, A. Brunmark, F. R. Carbone, P. A. Peterson, I. A. Wilson, and L. Teyton. 1996. CD8 enhances formation of stable T-cell receptor/MHC class I molecule complexes. Nature 384: 577-581.
8. Cole, D. K., and G. F. Gao. 2004. CD8: adhesion molecule, co-receptor and immuno-modulator. Cell. Mol. Immunol. 1: 81-88.
9. Gakamsky, D. M., I. F. Luescher, A. Pramanik, R. B. Kopito, F. Lemonnier, H. Vogel, R. Rigler, and I. Pecht. 2005. CD8 kinetically promotes ligand binding to the T-cell antigen receptor. Biophys. J. 89: 2121-2133.
10. Wyer, J. R., B. E. Willcox, G. F. Gao, U. C. Gerth, S. J. Davis, J. I. Bell, P. A. van der Merwe, and B. K. Jakobsen. 1999. T cell receptor and coreceptor CD8αα bind peptide-MHC independently and with distinct kinetics. Immunity 10: 219-225.
11. lck complexes. J. Exp. Med. 194: 1485-1495.
12. Knall, C., A. Ingold, and T. A. Potter. 1994. Analysis of coreceptor versus accessory molecule function of CD8 as a correlate of exogenous peptide concentration. Mol. Immunol. 31: 875-883.
13. Shen, L., T. A. Potter, and K. P. Kane. 1996. Glu227→Lys substitution in the acidic loop of major histocompatibility complex class I α3 domain distinguishes low avidity CD8 coreceptor and avidity-enhanced CD8 accessory functions. J. Exp. Med. 184: 1671-1683. (Pubitemid 26404460)
14. + CTLs. Int. Immunol. 19: 1413-1420.
15. Yachi, P. P., J. Ampudia, N. R. Gascoigne, and T. Zal. 2005. Nonstimulatory peptides contribute to antigen-induced CD8-T cell receptor interaction at the immunological synapse. Nat. Immunol. 6: 785-792.
16. McNicol, A. M., G. Bendle, A. Holler, T. Matjeka, E. Dalton, L. Rettig, R. Zamoyska, W. Uckert, S. A. Xue, and H. J. Stauss. 2007. CD8α/α homodimers fail to function as co-receptor for a CD8-dependent TCR. Eur. J. Immunol. 37: 1634-1641.
17. Cheroutre, H., and F. Lambolez. 2008. Doubting the TCR coreceptor function of CD8α/α. Immunity 28: 149-159.
18. Crooks, M. E., and D. R. Littman. 1994. Disruption of T lymphocyte positive and negative selection in mice lacking the CD8 β chain. Immunity 1: 277-285. (Pubitemid 124000668)
19. Fung-Leung, W. P., M. W. Schilham, A. Rahemtulla, T. M. Kundig, M. Vollenweider, J. Potter, W. van Ewijk, and T. W. Mak. 1991. CD8 is needed for development of cytotoxic T cells but not helper T cells. Cell 65: 443-449.
20. Nakayama, K., I. Negishi, K. Kuida, M. C. Louie, O. Kanagawa, H. Nakauchi, and D. Y. Loh. 1994. Requirement for CD8 β chain in positive selection of CD8-lineage T cells. Science 263: 1131-1133.
21. Terry, L. A., J. P. DiSanto, T. N. Small, and N. Flomenberg. 1990. Differential expression and regulation of the human CD8 α and CD8 β chains. Tissue Antigens 35: 82-91. (Pubitemid 20110508)
22. Moebius, U., G. Kober, A. L. Griscelli, T. Hercend, and S. C. Meuer. 1991. Expression of different CD8 isoforms on distinct human lymphocyte subpopulations. Eur. J. Immunol. 21: 1793-1800.
23. Van Laethem, F., S. D. Sarafova, J. H. Park, X. Tai, L. Pobezinsky, T. I. Guinter, S. Adoro, A. Adams, S. O. Sharrow, L. Feigenbaum, and A. Singer. 2007. Deletion of CD4 and CD8 coreceptors permits generation of αβT cells that recognize antigens independently of the MHC. Immunity 27: 735-750.
24. Gao, G. F., and B. K. Jakobsen. 2000. Molecular interactions of coreceptor CD8 and MHC class I: the molecular basis for functional coordination with the T-cell receptor. Immunol. Today 21: 630-636.
25. Gao, G. F., B. E. Willcox, J. R. Wyer, J. M. Boulter, C. A. O'Callaghan, K. Maenaka, D. I. Stuart, E. Y. Jones, P. A. Van Der Merwe, J. I. Bell, and B. K. Jakobsen. 2000. Classical and nonclassical class I major histocompatibility complex molecules exhibit subtle conformational differences that affect binding to CD8αα. J. Biol. Chem. 275: 15232-15238.
26. Kern, P., R. E. Hussey, R. Spoerl, E. L. Reinherz, and H. C. Chang. 1999. Expression, purification, and functional analysis of murine ectodomain fragments of CD8α/α and CD8α/β dimers. J. Biol. Chem. 274: 27237-27243. (Pubitemid 129520253)
27. Huang, J., L. J. Edwards, B. D. Evavold, and C. Zhu. 2007. Kinetics of MHC-CD8 interaction at the T cell membrane. J. Immunol. 179: 7653-7662.
28. Bosselut, R., L. Feigenbaum, S. O. Sharrow, and A. Singer. 2001. Strength of signaling by CD4 and CD8 coreceptor tails determines the number but not the lineage direction of positively selected thymocytes. Immunity 14: 483-494.
29. Witte, T., R. Spoerl, and H. C. Chang. 1999. The CD8δ ectodomain contributes to the augmented coreceptor function of CD8α/β heterodimers relative to CD8α/α homodimers. Cell. Immunol. 191: 90-96.
30. Merry, A. H., R. J. Gilbert, D. A. Shore, L. Royle, O. Miroshnychenko, M. Vuong, M. R. Wormald, D. J. Harvey, R. A. Dwek, B. J. Classon, et al. 2003. O-Glycan sialylation and the structure of the stalk-like region of the T cell coreceptor CD8. J. Biol. Chem. 278: 27119-27128.
31. Moody, A. M., D. Chui, P. A. Reche, J. J. Priatel, J. D. Marth, and E. L. Reinherz. 2001. Developmentally regulated glycosylation of the CD8αβ coreceptor stalk modulates ligand binding. Cell 107: 501-512.
32. Wong, J. S., X. Wang, T. Witte, L. Nie, N. Carvou, P. Kern, and H. C. Chang. 2003. Stalk region of δ-chain enhances the coreceptor function of CD8. J. Immunol. 171: 867-874.
33. Rettig, L., L. McNeill, N. Sarner, P. Guillaume, I. Luescher, M. Tolaini, D. Kioussis, and R. Zamoyska. 2009. An essential role for the stalk region of CD8β in the coreceptor function of CD8. J. Immunol. 182: 121-129.
34. Mallaun, M., D. Naeher, M. A. Daniels, P. P. Yachi, B. Hausmann, I. F. Luescher, N. R. Gascoigne, and E. Palmer. 2008. The T cell receptor's α-chain connecting peptide motif promotes close approximation of the CD8 coreceptor allowing efficient signal initiation. J. Immunol. 180: 8211-8221.
35. Salter, R. D., A. M. Norment, B. P. Chen, C. Clayberger, A. M. Krensky, D. R. Littman, and P. Parham. 1989. Polymorphism in the α3 domain of HLA-A molecules affects binding to CD8. Nature 338: 345-347.
36. Potter, T. A., T. V. Rajan, R. F. Dick, II, and J. A. Bluestone. 1989. Substitution at residue 227 of H-2 class I molecules abrogates recognition by CD8-dependent, but not CD8-independent, cytotoxic T lymphocytes. Nature 337: 73-75.
37. Potter, T. A., J. A. Bluestone, and T. V. Rajan. 1987. A single amino acid substitution in the α3 domain of an H-2 class I molecule abrogates reactivity with CTL. J. Exp. Med. 166: 956-966.
38. Salter, R. D., R. J. Benjamin, P. K. Wesley, S. E. Buxton, T. P. Garrett, C. Clayberger, A. M. Krensky, A. M. Norment, D. R. Littman, and P. Parham. 1990. A binding site for the T-cell co-receptor CD8 on the α3 domain of HLA-A2. Nature 345: 41-46.
39. Connolly, J. M., T. H. Hansen, A. L. Ingold, and T. A. Potter. 1990. Recognition by CD8 on cytotoxic T lymphocytes is ablated by several substitutions in the class I α domain: CD8 and the T-cell receptor recognize the same class I molecule. Proc. Natl. Acad. Sci. USA 87: 2137-2141. (Pubitemid 20105271)
40. Connolly, J. M., T. A. Potter, E. M. Wormstall, and T. H. Hansen. 1988. The Lyt-2 molecule recognizes residues in the class I α3 domain in allogeneic cytotoxic T cell responses. J. Exp. Med. 168: 325-341.
41. Sanders, S. K., R. O. Fox, and P. Kavathas. 1991. Mutations in CD8 that affect interactions with HLA class I and monoclonal anti-CD8 antibodies. J. Exp. Med. 174: 371-379.
42. Gao, G. F., J. Tormo, U. C. Gerth, J. R. Wyer, A. J. McMichael, D. I. Stuart, J. I. Bell, E. Y. Jones, and B. K. Jakobsen. 1997. Crystal structure of the complex between human CD8αα and HLA-A2. Nature 387: 630-634.
43. Devine, L., J. Sun, M. R. Barr, and P. B. Kavathas. 1999. Orientation of the Ig domains of CD8α(β) relative to MHC class I. J. Immunol. 162: 846-851. (Pubitemid 29035408)
44. Chang, H. C., K. Tan, and Y. M. Hsu. 2006. CD8αβ has two distinct binding modes of interaction with peptide-major histocompatibility complex class I. J. Biol. Chem. 281: 28090-28096.
45. Devine, L., D. Thakral, S. Nag, J. Dobbins, M. E. Hodsdon, and P. B. Kavathas. 2006. Mapping the binding site on CD8β for MHC class I reveals mutants with enhanced binding. J. Immunol. 177: 3930-3938. (Pubitemid 44359927)
46. d complexed with an immunodominant peptide from human immunodeficiency virus envelope glycoprotein 120. J. Mol. Biol. 283: 179-191.
47. Hogquist, K. A., A. J. Tomlinson, W. C. Kieper, M. A. McGargill, M. C. Hart, S. Naylor, and S. C. Jameson. 1997. Identification of a naturally occurring ligand for thymic positive selection. Immunity 6: 389-399.
48. Kern, P. S., M. K. Teng, A. Smolyar, J. H. Liu, J. Liu, R. E. Hussey, R. Spoerl, H. C. Chang, E. L. Reinherz, and J. H. Wang. 1998. Structural basis of CD8 coreceptor function revealed by crystallographic analysis of a murine CD8αα ectodomain fragment in complex with H-2Kb. Immunity 9: 519-530.
49. Chang, H. C., K. Tan, J. Ouyang, E. Parisini, J. H. Liu, Y. Le, X. Wang, E. L. Reinherz, and J. H. Wang. 2005. Structural and mutational analyses of a CD8αβ heterodimer and comparison with the CD8αα homodimer. Immunity 23: 661-671.
50. Corr, M., A. E. Slanetz, L. F. Boyd, M. T. Jelonek, S. Khilko, B. K. al-Ramadi, Y. S. Kim, S. E. Maher, A. L. Bothwell, and D. H. Margulies. 1994. T cell receptor-MHC class I peptide interactions: affinity, kinetics, and specificity. Science 265: 946-949.
51. Otwinowski, Z., and W. Minor. 1997. Processing of x-ray diffraction data collected in oscillation mode. In Methods in Enzymology. C. W. Carter, Jr. and R. M. Sweet, eds. Academic Press, New York, pp. 307-326.
52. Vagin, A., and A. Teplyakov. 1997. MOLREP: an automated program for molecular replacement. J. Appl. Crystallogr. 30: 1022-1025. (Pubitemid 127485985)
53. McCoy, A. J., R. W. Grosse-Kunstleve, P. D. Adams, M. D. Winn, L. C. Storoni, and R. J. Read. 2007. Phaser crystallographic software. J. Appl. Crystallogr. 40: 658-674.
54. CCP4. 1994. Collaborative computation project; the CCP4 suite: programs for protein crystallography. Acta Crystallogr. D 50: 760-763.
55. Tormo, J., K. Natarajan, D. H. Margulies, and R. A. Mariuzza. 1999. Crystal structure of a lectin-like natural killer cell receptor bound to its MHC class I ligand. Nature 402: 623-631. (Pubitemid 129516325)
56. Berman, H. M., J. Westbrook, Z. Feng, G. Gilliland, T. N. Bhat, H. Weissig, I. N. Shindyalov, and P. E. Bourne. 2000. The Protein Data Bank. Nucleic Acids Res. 28: 235-242.
57. Emsley, P., and K. Cowtan. 2004. Coot: model-building tools for molecular graphics. Acta Crystallogr. D 60: 2126-2132.
58. Brunger, A. T. 2007. Version 1.2 of the crystallography and NMR system. Nat. Protoc. 2: 2728-2733.
59. Adams, P. D., R. W. Grosse-Kunstleve, L. W. Hung, T. R. Ioerger, A. J. McCoy, N. W. Moriarty, R. J. Read, J. C. Sacchettini, N. K. Sauter, and T. C. Terwilliger. 2002. PHENIX: building new software for automated crystallographic structure determination. Acta Crystallogr. D 58: 1948-1954.
60. Laskowski, R. A., E. G. Hutchinson, A. D. Michie, A. C. Wallace, M. L. Jones, and J. M. Thornton. 1997. PDBsum: a Web-based database of summaries and analyses of all PDB structures. Trends Biochem. Sci. 22: 488-490.
61. Moody, A. M., Y. Xiong, H. C. Chang, and E. L. Reinherz. 2001. The CD8αβ co-receptor on double-positive thymocytes binds with differing affinities to the products of distinct class I MHC loci. Eur. J. Immunol. 31: 2791-2799.
62. Wooldridge, L., H. A. van den Berg, M. Glick, E. Gostick, B. Laugel, S. L. Hutchinson, A. Milicic, J. M. Brenchley, D. C. Douek, D. A. Price, and A. K. Sewell. 2005. Interaction between the CD8 coreceptor and major histocompatibility complex class I stabilizes T cell receptor-antigen complexes at the cell surface. J. Biol. Chem. 280: 27491-27501.
63. + T cells with Drosophila cell transfectants as antigen presenting cells. Immunol. Rev. 165: 249-265.
64. Yachi, P. P., J. Ampudia, T. Zal, and N. R. Gascoigne. 2006. Altered peptide ligands induce delayed CD8-T cell receptor interaction-a role for CD8 in distinguishing antigen quality. Immunity 25: 203-211.
65. Liu, Y., Y. Xiong, O. V. Naidenko, J. H. Liu, R. Zhang, A. Joachimiak, M. Kronenberg, H. Cheroutre, E. L. Reinherz, and J. H. Wang. 2003. The crystal structure of a TL/CD8αα complex at 2.1 A resolution: implications for modulation of T cell activation and memory. Immunity 18: 205-215.
66. Lawrence, M. C., and P. M. Colman. 1993. Shape complementarity at protein/protein interfaces. J. Mol. Biol. 234: 946-950.
67. Achour, A., K. Persson, R. A. Harris, J. Sundback, C. L. Sentman, Y. Lindqvist, G. Schneider, and K. Karre. 1998. The crystal structure of H-2Dd MHC class I complexed with the HIV-1-derived peptide P18-I10 at 2.4 A resolution: implications for T cell and NK cell recognition. Immunity 9: 199-208. (Pubitemid 28400033)
68. Devine, L., L. Rogozinski, O. V. Naidenko, H. Cheroutre, and P. B. Kavathas. 2002. The complementarity-determining region-like loops of CD8α interact differently with β2-microglobulin of the class I molecules H-2Kb and thymic leukemia antigen, while similarly with their α3 domains. J. Immunol. 168: 3881-3886. (Pubitemid 34298390)
69. Sekimata, M., M. Tanabe, A. Sarai, J. Yamamoto, A. Kariyone, H. Nakauchi, K. Egawa, and M. Takiguchi. 1993. Different effects of substitutions at residues 224 and 228 of MHC class I on the recognition of CD8. J. Immunol. 150: 4416-4426. (Pubitemid 23133718)
70. Durairaj, M., R. Sharma, J. C. Varghese, and K. P. Kane. 2003. Requirement for Q226, but not multiple charged residues, in the class I MHC CD loop/D strand for TCR-activated CD8 accessory function. Eur. J. Immunol. 33: 676-684.
71. Cohen, C. J., Y. F. Li, M. El-Gamil, P. F. Robbins, S. A. Rosenberg, and R. A. Morgan. 2007. Enhanced antitumor activity of T cells engineered to express T-cell receptors with a second disulfide bond. Cancer Res. 67: 3898-3903.
72. Cohen, C. J., Y. Zhao, Z. Zheng, S. A. Rosenberg, and R. A. Morgan. 2006. Enhanced antitumor activity of murine-human hybrid T-cell receptor (TCR) in human lymphocytes is associated with improved pairing and TCR/CD3 stability. Cancer Res. 66: 8878-8886.
73. Blue, M. L., K. A. Craig, P. Anderson, K. R. Branton, Jr., and S. F. Schlossman. 1988. Evidence for specific association between class I major histocompatibility antigens and the CD8 molecules of human suppressor/cytotoxic cells. Cell 54: 413-421.
74. Santos, S. G., S. J. Powis, and F. A. Arosa. 2004. Misfolding of major histocompatibility complex class I molecules in activated T cells allows cis-interactions with receptors and signaling molecules and is associated with tyrosine phosphorylation. J. Biol. Chem. 279: 53062-53070.
75. Gaspar, R., Jr., P. Bagossi, L. Bene, J. Matko, J. Szollosi, J. Tozser, L. Fesus, T. A. Waldmann, and S. Damjanovich. 2001. Clustering of class I HLA oligomers with CD8 and TCR: three-dimensional models based on fluorescence resonance energy transfer and crystallographic data. J. Immunol. 166: 5078-5086.
76. Bushkin, Y., S. Demaria, J. M. Le, and R. Schwab. 1988. Physical association between the CD8 and HLA class I molecules on the surface of activated human T lymphocytes. Proc. Natl. Acad. Sci. USA 85: 3985-3989.
77. Mancebo, E., M. A. Moreno-Pelayo, A. Mencia, O. de la Calle-Martin, L. M. Allende, P. Sivadorai, L. Kalaydjieva, J. Bertranpetit, E. Coto, S. Calleja-Antolin, et al. Gly111Ser mutation in CD8A gene causing CD8 immunodeficiency is found in Spanish Gypsies. Mol. Immunol. 45: 479-484.
78. de la Calle-Martin, O., M. Hernandez, J. Ordi, N. Casamitjana, J. I. Arostegui, I. Caragol, M. Ferrando, M. Labrador, J. L. Rodriguez-Sanchez, and T. Espanol. 2001. Familial CD8 deficiency due to a mutation in the CD8α gene. J. Clin. Invest. 108: 117-123.
79. Lee, B., and F. M. Richards. 1971. The interpretation of protein structures: estimation of static accessibility. J. Mol. Biol. 55: 379-400.
80. Saff, E. B., and A. B. J. Kuijlaars. 1997. Distributing many points on a sphere. Math. Intelligencer 19: 5-11.
81. Attinger, A., L. Devine, Y. Wang-Zhu, D. Martin, J. H. Wang, E. L. Reinherz, M. Kronenberg, H. Cheroutre, and P. Kavathas. 2005. Molecular basis for the high affinity interaction between the thymic leukemia antigen and the CD8αα molecule. J. Immunol. 174: 3501-3507.
82. Laskowski, R. A. PDBsum new things. 2009. Nucleic Acids Res. 37:D355-D359.
83. Gouet, P., X. Robert, and E. Courcelle. 2003. ESPript/ENDscript: extracting and rendering sequence and 3D information from atomic structures of proteins. Nucleic Acids Res. 31: 3320-3323.